UK
How Much Should We Spend on the NHS?
1 July 2004
Prior to the 2002 Spending Review Derek Wanless was asked by the Chancellor of The Exchequer to assess the ’financial and other resources required to ensure…
Developments in Economic Evaluation in Health Care: A Review of HEED
3 January 2004
Health care decision makers are becoming increasingly concerned with obtaining value for money and therefore with the use of economic evidence, particularly as a criterion for…
Reducing Harm to Patients in the National Health Service. Will the Government’s Compensation Proposals Help?
1 December 2003
The UK government hopes that the proposals in the report of the Department of Health’s Chief Medical Officer “Making Amends” (CMO, 2003) will make its NHS…
The Life Cycle of Pharmaceuticals: A Cross-National Perspective
1 April 2002
This study provides a life cycle perspective on cross-national differences in pharmaceutical prices, volumes and expenditures. Most previous studies have focused solely on cross-national differences in…
The Road to Sustainability in the UK and German Biotechnology Industries
1 August 2000
The UK and Germany are the European leaders in biotechnology. They have many more companies and employees in biotechnology, and much greater sums invested in biotechnology…
Surgical Research and Development in the NHS – Promotion, Management and Evaluation
1 July 2000
Based on papers delivered at the OHE Conference, London, 25 November 1997. Based on papers delivered at the OHE Conference, London, 25 November 1997. The UK…
Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison
1 June 2000
Most countries regulate manufacturer prices for pharmaceuticals, either directly (France, Italy) or indirectly through controls on reimbursement (Germany, Japan) or profits (the UK). It is widely…
Benchmarking and Incentives in the NHS
5 January 2000
This paper examines general issues in the use of benchmarking as a measure of comparative performance, reviews the application of benchmarking in the public and private…
Doctors, Economics and Clinical Practice Guidelines: Can they be brought together?
1 January 1999
The topic I have been asked to address, ‘Doctors, Economics and Clinical Practice Guidelines: Can they be Brought Together’, is both difficult and controversial. It is…